<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The majority of patients with recurrence of <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> after the initial <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> (AF) ablation procedure have resumption of pulmonary vein (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>) conduction </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="3" ids="16335">Adenosine</z:chebi>-infusion test after <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> isolation identifies <z:hpo ids='HP_0011009'>acute</z:hpo> dormant <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> conduction during the index procedure </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVE: To evaluate the utility of <z:chebi fb="3" ids="16335">adenosine</z:chebi>-infusion test at a repeat AF ablation procedure </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: This study included 50 consecutive patients (38 men; mean age 65±9 years) who underwent second ablation procedure for recurrent atrial tachyarrhythmia(s) </plain></SENT>
<SENT sid="4" pm="."><plain>At the index procedure, which was undertaken for paroxysmal AF, <z:hpo ids='HP_0000001'>all</z:hpo> patients underwent <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> isolation and 48 of 50 (96%) underwent superior vena cava (SVC) isolation followed by <z:chebi fb="3" ids="16335">adenosine</z:chebi> infusion </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> and SVC were reisolated---if found reconnected---at the start of the second procedure </plain></SENT>
<SENT sid="6" pm="."><plain>Thereafter, <z:chebi fb="3" ids="16335">adenosine</z:chebi>-infusion test was undertaken for <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PVs</z:e> in <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: At the index procedure, <z:chebi fb="3" ids="16335">adenosine</z:chebi> infusion revealed dormant <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> conduction in 15 of 50 (30%) patients </plain></SENT>
<SENT sid="8" pm="."><plain>At the second procedure, after 10±10 months, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> and SVC reconnections were observed in 46 of 50 (92%) and 33 of 48 (68.8%) patients and they were reisolated </plain></SENT>
<SENT sid="9" pm="."><plain>Subsequently, <z:chebi fb="3" ids="16335">adenosine</z:chebi>-infusion test revealed dormant <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> conduction in 9 of 50 (18%) patients, including 3 of 50 (6%) who had no <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> reconnection at the start of the procedure </plain></SENT>
<SENT sid="10" pm="."><plain>In these 3 patients, transient AF resulted after <z:chebi fb="3" ids="16335">adenosine</z:chebi> infusion, and at mean 8.0±3.4 months, they were free from any atrial <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> after the elimination of dormant <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> conduction alone </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: <z:chebi fb="3" ids="16335">Adenosine</z:chebi>-infusion test reveals dormant thoracic vein conduction associated with <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> recurrence in the <z:hpo ids='HP_0011010'>chronic</z:hpo> phase after the initial <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> isolation </plain></SENT>
</text></document>